{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:08:17Z","timestamp":1790629697535,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015579","name":"3M Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014943","name":"Sarepta Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014943","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.omtm.2021.06.010","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T08:58:40Z","timestamp":1624525120000},"page":"401-414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Systemic delivery of AAVrh74.tMCK.hCAPN3 rescues the phenotype in a mouse model for LGMD2A\/R1"],"prefix":"10.1016","volume":"22","author":[{"given":"Zarife","family":"Sahenk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcak","family":"Ozes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Murrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet E.","family":"Yalvac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Ridgley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry R.","family":"Mendell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2021.06.010_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0092-8674(95)90368-2","article-title":"Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A","volume":"81","author":"Richard","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2021.06.010_bib2","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/s41436-019-0544-8","article-title":"Estimating prevalence for limb-girdle muscular dystrophy based on public sequencing databases","volume":"21","author":"Liu","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.omtm.2021.06.010_bib3","series-title":"GeneReviews","article-title":"Calpainopathy","author":"Angelini","year":"1993"},{"key":"10.1016\/j.omtm.2021.06.010_bib4","doi-asserted-by":"crossref","first-page":"20106","DOI":"10.1016\/S0021-9258(19)47225-6","article-title":"Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m- and mu-types. Specific expression of the mRNA in skeletal muscle","volume":"264","author":"Sorimachi","year":"1989","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2021.06.010_bib5","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.1128\/MCB.23.24.9127-9135.2003","article-title":"Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components","volume":"23","author":"Taveau","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.omtm.2021.06.010_bib6","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/bi051917j","article-title":"Ca2+ dependency of calpain 3 (p94) activation","volume":"45","author":"Garc\u00eda D\u00edaz","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.omtm.2021.06.010_bib7","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1093\/hmg\/ddr239","article-title":"Pathogenity of some limb girdle muscular dystrophy mutations can result from reduced anchorage to myofibrils and altered stability of calpain 3","volume":"20","author":"Ermolova","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.06.010_bib8","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/j.jmb.2013.05.009","article-title":"PLEIAD\/SIMC1\/C5orf25, a novel autolysis regulator for a skeletal-muscle-specific calpain, CAPN3, scaffolds a CAPN3 substrate, CTBP1","volume":"425","author":"Ono","year":"2013","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.omtm.2021.06.010_bib9","doi-asserted-by":"crossref","first-page":"31158","DOI":"10.1074\/jbc.270.52.31158","article-title":"Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence","volume":"270","author":"Sorimachi","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2021.06.010_bib10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbadis.2006.07.002","article-title":"Molecular and cellular basis of calpainopathy (limb girdle muscular dystrophy type 2A)","volume":"1772","author":"Kramerova","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2021.06.010_bib11","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/hmg\/ddh153","article-title":"Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in\u00a0vivo and in\u00a0vitro","volume":"13","author":"Kramerova","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.06.010_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s002329900312","article-title":"Identification, characterization and partial purification of a thiol-protease which cleaves specifically the skeletal muscle ryanodine receptor\/Ca2+ release channel","volume":"161","author":"Shevchenko","year":"1998","journal-title":"J.\u00a0Membr. Biol."},{"key":"10.1016\/j.omtm.2021.06.010_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00232-005-0749-4","article-title":"The voltage-dependent anion channel in endoplasmic\/sarcoplasmic reticulum: characterization, modulation and possible function","volume":"204","author":"Shoshan-Barmatz","year":"2005","journal-title":"J.\u00a0Membr. Biol."},{"key":"10.1016\/j.omtm.2021.06.010_bib14","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1093\/hmg\/ddn223","article-title":"Novel role of calpain-3 in the triad-associated protein complex regulating calcium release in skeletal muscle","volume":"17","author":"Kramerova","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.06.010_bib15","doi-asserted-by":"crossref","first-page":"15492","DOI":"10.1073\/pnas.1507176112","article-title":"Ryanodine receptor fragmentation and sarcoplasmic reticulum Ca2+ leak after one session of high-intensity interval exercise","volume":"112","author":"Place","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2021.06.010_bib16","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1093\/hmg\/dds144","article-title":"Impaired calcium calmodulin kinase signaling and muscle adaptation response in the absence of calpain 3","volume":"21","author":"Kramerova","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.06.010_bib17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jmb.2011.01.057","article-title":"Non-proteolytic functions of calpain-3 in sarcoplasmic reticulum in skeletal muscles","volume":"407","author":"Ojima","year":"2011","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.omtm.2021.06.010_bib18","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1093\/hmg\/ddp257","article-title":"Mitochondrial abnormalities, energy deficit and oxidative stress are features of calpain 3 deficiency in skeletal muscle","volume":"18","author":"Kramerova","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.06.010_bib19","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1093\/hmg\/ddw086","article-title":"Failure to up-regulate transcription of genes necessary for muscle adaptation underlies limb girdle muscular dystrophy 2A (calpainopathy)","volume":"25","author":"Kramerova","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.06.010_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13395-016-0081-y","article-title":"Attenuated Ca(2+) release in a mouse model of limb girdle muscular dystrophy 2A","volume":"6","author":"DiFranco","year":"2016","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omtm.2021.06.010_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13395-017-0146-6","article-title":"Impaired regeneration in calpain-3 null muscle is associated with perturbations in mTORC1 signaling and defective mitochondrial biogenesis","volume":"7","author":"Yalvac","year":"2017","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omtm.2021.06.010_bib22","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1017\/erm.2016.9","article-title":"Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle","volume":"18","author":"Toral-Ojeda","year":"2016","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.omtm.2021.06.010_bib23","doi-asserted-by":"crossref","first-page":"e102549","DOI":"10.1371\/journal.pone.0102549","article-title":"Redox state and mitochondrial respiratory chain function in skeletal muscle of LGMD2A patients","volume":"9","author":"Nilsson","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2021.06.010_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/jnen\/nly113","article-title":"Divergent Features of Mitochondrial Deficiencies in LGMD2A Associated With Novel Calpain-3 Mutations","volume":"78","author":"El-Khoury","year":"2019","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.omtm.2021.06.010_bib25","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s11064-013-1107-z","article-title":"Oxidative stress, NF-\u03baB and the ubiquitin proteasomal pathway in the pathology of calpainopathy","volume":"38","author":"Rajakumar","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.omtm.2021.06.010_bib26","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.3390\/ijms20184548","article-title":"Calcium Mechanisms in Limb-Girdle Muscular Dystrophy with CAPN3 Mutations","volume":"20","author":"Lasa-Elgarresta","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2021.06.010_bib27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ymthe.2005.09.017","article-title":"Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A","volume":"13","author":"Bartoli","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.06.010_bib28","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCULATIONAHA.113.001340","article-title":"Restriction of calpain3 expression to the skeletal muscle prevents cardiac toxicity and corrects pathology in a murine model of limb-girdle muscular dystrophy","volume":"128","author":"Roudaut","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.omtm.2021.06.010_bib29","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/gt.2008.104","article-title":"Construction and analysis of compact muscle-specific promoters for AAV vectors","volume":"15","author":"Wang","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2021.06.010_bib30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5414\/NP300728","article-title":"Gender difference in limb-girdle muscular dystrophy: a muscle fiber morphometric study in 101 patients","volume":"33","author":"Fanin","year":"2014","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.omtm.2021.06.010_bib31","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/er.2006-0037","article-title":"Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism","volume":"27","author":"Handschin","year":"2006","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.omtm.2021.06.010_bib32","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nature00904","article-title":"Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres","volume":"418","author":"Lin","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2021.06.010_bib33","doi-asserted-by":"crossref","first-page":"9013","DOI":"10.1074\/jbc.M212923200","article-title":"The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha)","volume":"278","author":"Schreiber","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2021.06.010_bib34","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1212\/WNL.56.5.692-a","article-title":"Normal calpain expression in genetically confirmed limb-girdle muscular dystrophy type 2A","volume":"56","author":"Talim","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.omtm.2021.06.010_bib35","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/01.jnen.0000235854.77716.6c","article-title":"Limb-girdle muscular dystrophy in the United States","volume":"65","author":"Moore","year":"2006","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.omtm.2021.06.010_bib36","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0002-9440(10)65661-1","article-title":"Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A","volume":"153","author":"Anderson","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2021.06.010_bib37","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1177\/002215540004800506","article-title":"Fiber type composition of the vastus lateralis muscle of young men and women","volume":"48","author":"Staron","year":"2000","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.omtm.2021.06.010_bib38","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1096\/fj.14-255000","article-title":"The human skeletal muscle transcriptome: sex differences, alternative splicing, and tissue homogeneity assessed with RNA sequencing","volume":"28","author":"Lindholm","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.omtm.2021.06.010_bib39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jss.2013.05.054","article-title":"Gastrocnemius mitochondrial respiration: are there any differences between men and women?","volume":"185","author":"Thompson","year":"2013","journal-title":"J.\u00a0Surg. Res."},{"key":"10.1016\/j.omtm.2021.06.010_bib40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1152\/jappl.1976.40.2.149","article-title":"Skeletal muscle enzymes and fiber composition in male and female track athletes","volume":"40","author":"Costill","year":"1976","journal-title":"J.\u00a0Appl. Physiol."},{"key":"10.1016\/j.omtm.2021.06.010_bib41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1748-1716.2006.01620.x","article-title":"Human skeletal muscle fibre type variations correlate with PPAR alpha, PPAR delta and PGC-1 alpha mRNA","volume":"188","author":"Kr\u00e4mer","year":"2006","journal-title":"Acta Physiol. (Oxf.)"},{"key":"10.1016\/j.omtm.2021.06.010_bib42","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.2337\/db11-0121","article-title":"Reduction in reactive oxygen species production by mitochondria from elderly subjects with normal and impaired glucose tolerance","volume":"60","author":"Ghosh","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.omtm.2021.06.010_bib43","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.exger.2013.08.004","article-title":"Exercise training attenuates aging-associated mitochondrial dysfunction in rat skeletal muscle: role of PGC-1\u03b1","volume":"48","author":"Kang","year":"2013","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.omtm.2021.06.010_bib44","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1073\/pnas.0501559102","article-title":"Decline in skeletal muscle mitochondrial function with aging in humans","volume":"102","author":"Short","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2021.06.010_bib45","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.addr.2009.06.006","article-title":"Mitochondrial biogenesis in exercise and in ageing","volume":"61","author":"Vi\u00f1a","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtm.2021.06.010_bib46","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.bbagrm.2008.03.001","article-title":"MicroRNA-206: the skeletal muscle-specific myomiR","volume":"1779","author":"McCarthy","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2021.06.010_bib47","doi-asserted-by":"crossref","first-page":"eaat6072","DOI":"10.1126\/scitranslmed.aat6072","article-title":"Titin splicing regulates cardiotoxicity associated with calpain 3 gene therapy for limb-girdle muscular dystrophy type 2A","volume":"11","author":"Lostal","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2021.06.010_bib48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/geno.1997.5160","article-title":"Expression of genes (CAPN3, SGCA, SGCB, and TTN) involved in progressive muscular dystrophies during early human development","volume":"48","author":"Fougerousse","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.omtm.2021.06.010_bib49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.biochi.2015.09.010","article-title":"An eccentric calpain, CAPN3\/p94\/calpain-3","volume":"122","author":"Ono","year":"2016","journal-title":"Biochimie"},{"key":"10.1016\/j.omtm.2021.06.010_bib50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0960-8966(99)00107-8","article-title":"Calpain3 expression during human cardiogenesis","volume":"10","author":"Fougerousse","year":"2000","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2021.06.010_bib51","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/mus.10368","article-title":"Force impairment in calpain 3-deficient mice is not correlated with mechanical disruption","volume":"27","author":"Fougerousse","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2021.06.010_bib52","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2021.06.010_bib53","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jamaneurol.2020.1484","article-title":"Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial","volume":"77","author":"Mendell","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.omtm.2021.06.010_bib54","first-page":"49","article-title":"Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy","volume":"19","author":"Powell","year":"2015","journal-title":"Discov. Med."},{"key":"10.1016\/j.omtm.2021.06.010_bib55","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/10430349950018427","article-title":"Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses","volume":"10","author":"Clark","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2021.06.010_bib56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41587-020-0613-1","article-title":"Inducible de novo expression of neoantigens in tumor cells and mice","volume":"39","author":"Damo","year":"2021","journal-title":"Nat. Biotechnol."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121001121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121001121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:28:17Z","timestamp":1762421297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050121001121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":56,"alternative-id":["S2329050121001121"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2021.06.010","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic delivery of AAVrh74.tMCK.hCAPN3 rescues the phenotype in a mouse model for LGMD2A\/R1","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2021.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}]}}